Document is current

Any future updates will be listed below

Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies

Crossref DOI link: https://doi.org/10.1007/s10637-015-0277-8

Published Online: 2015-08-16

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark